What do Neil Woodford’s woes mean for Woodford Patient Capital?

Woodford Patient Capital Trust plc (LON: WCT) shares have plunged to a discount of nearly 50%. Is that a strong buy signal?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Since the news broke that Neil Woodford’s suspension of his flagship Woodford Equity Income fund is to continue at least until December, investors have renewed their sell-off of his Woodford Patient Capital (LSE: WPCT) investment trust.

Since the announcement on 29 July, the shares have shed a further 16% of their value, though some of that will have been spurred by a short-selling attack from US short-seller Muddy Waters on one of Woodford’s key holdings, Burford Capital. Woodford Investment has seen its stake fall by £118m.

Selling

To further dent confidence, Woodford himself has joined the sellers’ ranks and has offloaded more than £1m in WPCT shares. Investors are critical of the delay in announcing the sale, which apparently took place between 3 and 8 July when the shares were in the 56p to 58p range. They’ve subsequently fallen to 42p.

The sale, which comes at a time when Woodford is being roundly slated for continuing to charge management fees on the suspended Woodford Equity Income fund while its investors can’t get their hands on their cash, was apparently to raise money to pay a tax bill. Having to sell shares to meet what is surely an easily foreseeable expense strikes me as poor personal finance management — in his position, I’d have made sure I had a few million in the bank to cover such things.

Management change?

Questions now hang over whether Neil Woodford is finished as an investment manager, and what shareholders should do about Woodford Patient Capital shares.

The first question, at least as far as managing the investment trust goes, is very much open. The board of Woodford Patient Capital is in talks with investment management companies “which may or may not lead to a change in the company’s management arrangements.”

Concerns from some quarters that the trust has come close to breaching its 80% limit on unquoted investments will, in my view, pile on even more pressure to dump Woodford.

Buy or sell?

As for what individual investors should do now, at 42p WPCT shares are on a whopping 48% discount to estimated NAV. Now, we don’t know what effect Woodford’s rebalancing of his funds might have on that, and it’s hard to be sure of accurate NAV values anyway when so much is invested in unquoted and volatile companies.

I would only make a long-term investment in Woodford Patient Capital if I wanted to invest in its underlying assets, as I would with any such trust. But right now, while all of Woodford’s investments are in turmoil, the company is only listing its top 10 holdings — and I’ve no idea what it will look like when things settle.

Short-term bargain?

But over the shorter term, I can’t help wondering if we’re looking at an oversold bargain. The trust has said that, once it has reduced its gearing, it “intends to undertake share repurchases in order to seek to mitigate the discount to NAV” if it’s still high.

I don’t want to invest in WPCT for the long term as I don’t share its liking for unquoted ‘blue sky’ investments. And I don’t do short-term investments… but you know, I just might, just this once.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »